Broach Lifecare Hospital Ltd Share Price

Audited Standalone Financial Results of the company for the half year and year ended on March 31 2026 along with Auditors Report under Reg 33 of SEBI (LODR) Regulations 2015.

We hereby inform that Board of Directors of company at its meeting held today i.e. May 21 2026 inter alia have considered approved and taken on record inter-alia the following businesses: 1. Audited Standalone Financial Results of the Company for the Half Year and Year ended March 31 2026 in terms of Regulation 33 of the Listing Obligations; 2. Considered and approved other business matters as per the Agenda including any Other Business matters with the approval of the Chairman. A copy of the Audited Standalone Financial Results of the Company for the Half-Year and Year ended March 31 2026 along with the Auditors Report declaration with respect to the Audit Report with unmodified opinion on the Audited Standalone Financial Results Statement of deviation(s) and variation(s) Certificate of Correctness of financial results have been enclosed herewith. Kindly note that the meeting of the Board of Directors of the Company commenced at 04.00 p.m. and concluded at 06.15 pm.

Statement of Deviations and variations of funds raised through public issue (IPO) under Reg 32(1) if SEBI (LODR) Regulations 2015 as on March 31 2026 pursuant to allotment of equity shares on public issue (IPO).

Pursuant to Reg 30 of SEBI(LODR) Regulations 2015 we hereby submit duly signed audited standalone financial results for the half year and financial year ended on March 31 2026 along with Auditors report under reg. 33 of SEBI (LODR) Regulations 2015.